Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Navarra (11)

2024

  1. Prevalence of potentially inappropriate medications and prescription dynamics in elderly hospitalized patients in Spain

    BMC Geriatrics, Vol. 24, Núm. 1

2023

  1. Effect of the combination of diuretics, renin–angiotensin–aldosterone system inhibitors, and non-steroidal anti-inflammatory drugs or metamizole (triple whammy) on hospitalisation due to acute kidney injury: A nested case–control study

    Pharmacoepidemiology and Drug Safety, Vol. 32, Núm. 8, pp. 898-909

2021

  1. Consumption of ultra-processed foods and drinks and colorectal, breast, and prostate cancer

    Clinical Nutrition, Vol. 40, Núm. 4, pp. 1537-1545

  2. Sleep duration and napping in relation to colorectal and gastric cancer in the MCC-Spain study

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses

    BMC medicine, Vol. 18, Núm. 1, pp. 229

  2. Quality of life in a cohort of 1078 women diagnosed with breast cancer in spain: 7-year follow-up results in the mcc-spain study

    International Journal of Environmental Research and Public Health, Vol. 17, Núm. 22, pp. 1-16

2019

  1. Heterogeneity of Colorectal Cancer Risk Factors by Anatomical Subsite in 10 European Countries: A Multinational Cohort Study

    Clinical Gastroenterology and Hepatology, Vol. 17, Núm. 7, pp. 1323-1331.e6

  2. Moderate egg consumption and all-cause and specific-cause mortality in the Spanish European Prospective into Cancer and Nutrition (EPIC-Spain) study

    European Journal of Nutrition, Vol. 58, Núm. 5, pp. 2003-2010

2018

  1. Childhood and adolescent lymphoma in Spain: incidence and survival trends over 20 years

    Clinical and Translational Oncology, Vol. 20, Núm. 10, pp. 1289-1301

  2. Comorbidities and cardiovascular risk factors in an aged cohort of HIV-infected patients on antiretroviral treatment in a Spanish hospital in 2016

    Postgraduate Medicine, Vol. 130, Núm. 3, pp. 317-324

  3. Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: Results from the EPIC cohort

    BMC Cancer, Vol. 18, Núm. 1